---

Related Articles:

Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.

2011-11-01

[J. Sex. Med. 8(11) , 3160-72, (2011)]

Open-label extension study of flibanserin in women with hypoactive sexual desire disorder.

2012-12-01

[J. Sex. Med. 9(12) , 3180-8, (2012)]

Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.

2011-12-01

[J. Sex. Med. 8(12) , 3262-70, (2011)]

Population pharmacokinetic/pharmacodynamic model for the sedative effects of flibanserin in healthy volunteers.

2012-06-01

[Pharm. Res. 29(6) , 1518-29, (2012)]

Resurgence of interest in sexual dysfunction?

2012-06-01

[BJU Int. 109(11) , E36-7, (2012)]